These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9207307)

  • 21. Prolonged gemcitabine infusion in advanced non-small cell lung carcinoma: a randomized phase II study of two different schedules in combination with cisplatin.
    Ceribelli A; Gridelli C; De Marinis F; Fabi A; Gamucci T; Cortesi E; Barduagni M; Antimi M; Maione P; Migliorino MR; Giannarelli D; Cognetti F
    Cancer; 2003 Jul; 98(2):337-43. PubMed ID: 12872354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preclinical, pharmacologic, and phase I studies of gemcitabine.
    Storniolo AM; Allerheiligen SR; Pearce HL
    Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-2-S7-7. PubMed ID: 9194473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of a phase II trial of gemcitabine in patients with non-small-cell lung cancer and a performance status of 2.
    Neubauer MA; Reynolds CH; Joppert MG; Whitaker T; Ghaddar H; Marsland TA; Asmar L
    Clin Lung Cancer; 2005 Jan; 6(4):245-9. PubMed ID: 15694017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preclinical studies of gemcitabine and trastuzumab in breast and lung cancer cell lines.
    Hirsch FR; Helfrich B; Franklin WA; Varella-Garcia M; Chan DC; Bunn PA
    Clin Breast Cancer; 2002 May; 3 Suppl 1():12-6. PubMed ID: 12057039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical case of the month. Pulmonary toxicity due to gemcitabine for NSCLC with brain metastasis].
    Mommens V; Bosquée L; D'Orio V
    Rev Med Liege; 2003 Mar; 58(3):123-6. PubMed ID: 12723505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the cytotoxic activity of gemcitabine in primary cultures of tumor cells from patients with hematologic or solid tumors.
    Csoka K; Liliemark J; Larsson R; Nygren P
    Semin Oncol; 1995 Aug; 22(4 Suppl 11):47-53. PubMed ID: 7481845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted therapy in combination with gemcitabine in non-small cell lung cancer.
    Rosell R; Crino L; Danenberg K; Scagliotti G; Bepler G; Taron M; Alberola V; Provencio M; Camps C; De Marinis F; Sanchez JJ; Peñas R
    Semin Oncol; 2003 Aug; 30(4 Suppl 10):19-25. PubMed ID: 12917817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [First-line non-small-cell lung cancer: role of gemcitabine].
    Barata F
    Rev Pneumol Clin; 2005 Sep; 61(4 Pt 2):4S20-2. PubMed ID: 16273006
    [No Abstract]   [Full Text] [Related]  

  • 29. 13-cis-Retinoic acid in combination with gemcitabine in the treatment of locally advanced and metastatic pancreatic cancer--report of a pilot phase II study.
    Michael A; Hill M; Maraveyas A; Dalgleish A; Lofts F
    Clin Oncol (R Coll Radiol); 2007 Mar; 19(2):150-3. PubMed ID: 17355112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is long term gemcitabine useful in small cell lung cancer?
    Dediu M
    Lung Cancer; 2002 May; 36(2):217-8. PubMed ID: 11955659
    [No Abstract]   [Full Text] [Related]  

  • 31. [The role of gemcitabine in hematology].
    Dumontet C
    Bull Cancer; 2002 Aug; 89 Spec No():S123-6. PubMed ID: 12449043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gemcitabine for lung cancer.
    Drug Ther Bull; 1996 Sep; 34(9):71-2. PubMed ID: 8885499
    [No Abstract]   [Full Text] [Related]  

  • 33. The role of deoxycytidine kinase in gemcitabine cytotoxicity.
    van der Wilt CL; Kroep JR; Bergman AM; Loves WJ; Alvarez E; Talianidis I; Eriksson S; van Groeningen CJ; Pinedo HM; Peters GJ
    Adv Exp Med Biol; 2000; 486():287-90. PubMed ID: 11783501
    [No Abstract]   [Full Text] [Related]  

  • 34. Gemcitabine--a new agent in the treatment of non-small cell lung cancer. A commentary.
    Carmichael J
    Lung Cancer; 1999 Aug; 25(2):73-5. PubMed ID: 10470840
    [No Abstract]   [Full Text] [Related]  

  • 35. Genetic polymorphism of XRCC1 Arg399Gln is associated with survival in non-small-cell lung cancer patients treated with gemcitabine/platinum.
    Liao WY; Shih JY; Chang GC; Cheng YK; Yang JC; Chen YM; Yu CJ
    J Thorac Oncol; 2012 Jun; 7(6):973-81. PubMed ID: 22551904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gemcitabine and UFT plus oral calcium folinate: phase I study.
    Philip PA; Ibrahim D; Zalupski M; Arlauskas P; Shields A
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):116-9. PubMed ID: 10442378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II trial of gemcitabine and weekly cisplatin for advanced non-small cell lung cancer.
    Shepherd FA; Cormier Y; Burkes R; Evans WK; Goss G; Klimo P; Feld R; Taylor M
    Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-27-S8-30. PubMed ID: 9207313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-dose gemcitabine in long infusion: when less is more.
    Zwitter M
    Indian J Cancer; 2012; 49(2):199-201. PubMed ID: 23107970
    [No Abstract]   [Full Text] [Related]  

  • 39. Radiation myositis: the possible role of gemcitabine.
    Ganem G; Solal-Celigny P; Joffroy A; Tassy D; Delpon A; Dupuis O
    Ann Oncol; 2000 Dec; 11(12):1615-6. PubMed ID: 11205473
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of new drugs in small cell lung cancer: the activity of gemcitabine.
    Postmus PE; Schramel FM; Smit EF
    Semin Oncol; 1998 Aug; 25(4 Suppl 9):79-82. PubMed ID: 9728590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.